South Africa: NHA Medscheme Fisher High Court Judgment Dismisses Arbitration Review

• The High Court in Johannesburg dismissed Neil Harvey & Associates' (NHA) application to review and set aside an arbitration award in its 17-year dispute with Medscheme.
• Judge Denise Fisher's ruling, handed down on Monday, upheld an appeal tribunal's award from 15 August 2025, which had dismissed NHA's claims of unlawful competition, misuse of confidential information, and trade secrets.
• NHA argued that the appeal tribunal committed a 'gross irregularity' under the Arbitration Act by failing to consider its contention that the initial arbitrator neglected to examine detailed pleadings regarding its unfair competition case.
• Medscheme and the tribunal members contended that NHA's application was an attempt to re-litigate the case as an appeal rather than a legitimate review.
• The judgment reinforces the strict limitations on High Court intervention in arbitration awards, emphasizing that reviews are not intended for re-evaluation of the dispute's merits.

The court's decision implicitly reinforces that such reviews are not opportunities to re-litigate the merits of a dispute, but rather to assess specific procedural irregularities or misconduct.

A long-standing 17-year dispute between software developer Neil Harvey & Associates (NHA) and medical aid scheme administrator Medscheme recently saw a new development in the High Court in Johannesburg. Judge Denise Fisher, presiding over the matter, dismissed with costs an application by NHA that sought to review and set aside an arbitration award. The judgment, handed down on Monday, represents a significant setback for NHA in its protracted legal battle.

NHA's application specifically aimed to challenge an award delivered by an appeal tribunal on 15 August 2025. The software developer had requested that the High Court not only overturn this award but also remit the case to a new appeal tribunal for fresh consideration. The core of NHA's grievance revolved around allegations of unlawful competition, misuse of confidential information, and trade secrets against Medscheme.

The origins of the Neil Harvey & Associates Medscheme dispute trace back to a period before 2003. At that time, Medscheme utilized its proprietary software, initially named Pulse and later rebranded as Nexus, for the administration of medical schemes. In 2003, Medscheme entered into an agreement to license Medware, NHA's product, for use with four of the 23 medical schemes it managed, while continuing to employ Nexus for the remaining schemes. Medscheme is owned by JSE-listed healthcare company AfroCentric Investment Corporation and insurance giant Sanlam.

Following the breakdown of their contractual relationship, NHA initiated claims against Medscheme in 2007. Later that same year, both parties mutually agreed to refer their disagreements to arbitration. NHA presented three broad claims during the arbitration proceedings. A separate issue concerning copyright infringement of the Medware product known as EMI was adjudicated in 2020, resulting in an order for Medscheme to pay R2.7 million, which has since been settled. However, the remaining claims were dismissed by the initial arbitrator in March 2024, a decision subsequently upheld by the appeal tribunal on 15 August 2025. NHA accepted the valid dismissal of its contractual claim, directing its High Court review application solely at the dismissal of its claims related to trade secrets, confidential information, and unlawful competition.

NHA's application for a South Africa arbitration award review hinged on an assertion of gross irregularity by the appeal tribunal, a ground for review under the Arbitration Act. The software developer contended that the arbitrator had failed to properly examine the detailed facts and evidence presented in Annexure C6, a crucial pleading supporting NHA's claims of unlawful competition, misuse of confidential information, and trade secrets. Instead, NHA argued, the arbitrator analyzed the case in 'broad strokes,' effectively failing to consider NHA's unfair competition case at all.

NHA further argued that it had raised this specific failure as a ground of appeal before the tribunal, but the tribunal did not consider it. According to NHA, this omission by the appeal tribunal constituted a gross irregularity, making the award reviewable. NHA posited that a proper engagement with this ground of appeal would have led the tribunal to conclude that the arbitrator erred in not addressing the case as pleaded in Annexure C6, and the tribunal should have then addressed it itself or referred it to a new appeal tribunal for proper consideration. NHA also asserted that by not considering this ground, the tribunal failed to decide the unfair competition case as pleaded or at all, thereby violating its mandate under the arbitration agreement. Medscheme and the appeal tribunal members countered these arguments, asserting that NHA's application was merely an attempt to pursue a further appeal disguised as a review, and disputed that the specific ground of appeal NHA now relied upon was ever properly before the tribunal.

In her judgment, Judge Denise Fisher found against NHA, dismissing its application with costs. This NHA Medscheme Fisher High Court judgment underscores the narrow scope available for High Court review of arbitration awards in South Africa, particularly when challenging decisions of an appeal tribunal. The court's decision implicitly reinforces that such reviews are not opportunities to re-litigate the merits of a dispute, but rather to assess specific procedural irregularities or misconduct.

Judge Fisher noted that NHA's notice of appeal had criticised the arbitrator's analysis of facts and law, and alleged errors in the evaluation and proper assessment of evidence. However, the High Court ultimately found that NHA's arguments did not meet the stringent criteria required under the Arbitration Act to set aside the appeal tribunal's award on grounds of gross irregularity. This outcome serves as a pertinent reminder for legal practitioners regarding the high threshold for successfully challenging arbitration awards.

This judgment reinforces the narrow scope for High Court review of arbitration awards in South Africa, particularly concerning allegations of gross irregularity by an appeal tribunal. Lawyers advising on arbitration should note the court's emphasis on the specific grounds required under the Arbitration Act to successfully challenge an award, rather than attempting to re-litigate the merits of the dispute.

Source: Original reporting via Moneyweb